filmov
tv
Pre-clinical AAV production and optimization: Not as easy as it looks! | GenScript
Показать описание
This webcast will discuss:
Introduction to AAV in gene therapy.
Some recent advances in viral vector production.
Current challenges and solutions of pre-clinical AAV production.
Adeno-associated virus (AAV) is the most popular vector of choice for gene therapy because of its low immunogenicity and ability to infect numerous cells and tissue types. However, with hundreds of gene therapy trials ongoing, manufacturing large quantities of viral vectors is becoming an increasing challenge.
Services GenScript offers related to the topics discussed:
Introduction to AAV in gene therapy.
Some recent advances in viral vector production.
Current challenges and solutions of pre-clinical AAV production.
Adeno-associated virus (AAV) is the most popular vector of choice for gene therapy because of its low immunogenicity and ability to infect numerous cells and tissue types. However, with hundreds of gene therapy trials ongoing, manufacturing large quantities of viral vectors is becoming an increasing challenge.
Services GenScript offers related to the topics discussed:
0:52:00
Pre-clinical AAV production and optimization: Not as easy as it looks! | GenScript
0:38:52
Optimizing Transfection to Generate High Titer AAV and Lentiviral Vectors
0:01:51
Optimizing AAV vectors with AI
0:09:05
Expert Interview Series: ITR and Preclinical Plasmid
0:42:33
Preclinical Assessment of Investigational Gene Therapy Products for Neuroscience
0:43:52
Discovering the Next Generation AAV Vector- Capsid Engineering & Expression Cassette Optimizatio...
1:24:54
Scalable AAV manufacturing: addressing challenges across the workflow
0:40:59
Unlocking the power of AAV and LVV Analytics: Insights and strategies for optimizing viral vector...
0:32:51
High titer adeno-associated virus (AAV) production that is Cost-effective and Scalable
0:04:03
Comparing viral protein quantities between AAV batches | Identifying problematic Sf9 and AcMNPV HCPs
0:00:55
Clinical challenges in developing AAV-based gene therapies
1:01:31
Innovations in viral vector development, scale up and production webinar
0:55:51
Directed Evolution of Next-Generation AAV Vector Systems for Clinical Gene Therapy
0:06:15
Characterization of AAV Vector Persistence After Long-Term Follow-up in the Hemophilia A Dog Model
0:25:59
Advancing AAV: Novel Synthesis and Sequencing Solutions for Gene Therapy Research
0:47:14
Analytical Ultracentrifugation for Characterization of AAV Gene Delivery Vectors
0:53:28
Solutions for Viral Vectors: Enabling Platform Approaches to Advance Cell and Gene Therapies
0:47:03
How LV and AAV Transfection Platforms will Shape the Future of Gene Therapy Manufacturing
0:05:10
Can We Streamline How AAV Gene Therapies Are Developed?
1:10:27
In the Pipeline: Pre-Clinical Gene Therapy (PPMD's 2021 Virtual Annual Conference)
0:01:42
BGTC: AAV Animation
0:38:30
Enabling Large-Scale Production of Viral Vectors in the Gibco™ CTS LV-MAX Lentiviral....
0:58:30
AAV Vector Shedding Assay—Best Practices in Clinical Gene Therapy Method Development
0:12:32
Introduction to preclinical cancer research by Jeroen Pouwels, Cancer IO
Комментарии